News
Zacks Investment Research on MSN15d
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharmaBayer BAYRY announced a licensing agreement with Suzhou Puhe BioPharma Co., a clinical-stage biotechnology company.Suzhou ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback